Asian Journal of Medicine and Health 2023-02-04T10:40:29+00:00 Asian Journal of Medicine and Health Open Journal Systems <p style="text-align: justify;"><strong>Asian Journal of Medicine and Health</strong>&nbsp;<strong>(ISSN: 2456-8414)</strong>&nbsp;aims to publish high quality papers (<a href="/index.php/AJMAH/general-guideline-for-authors">Click here for Types of paper</a>) in the areas of Medicine and Health Science. By not excluding papers based on novelty, this journal facilitates the research and wishes to publish papers as long as they are technically correct and scientifically motivated. The journal also encourages the submission of useful reports of negative results. This is a quality controlled, OPEN peer-reviewed, open-access INTERNATIONAL journal.</p> Risk Factors of Acute Malnutrition among Children Under Five Years of Age 2023-02-01T12:17:31+00:00 Yousef M. Alflah Mohammed A. Alrashidi <p>Childhood malnutrition remains a significant global public health concern, and despite numerous advances and improvements in child health care; acute malnutrition among children still one of the main public health challenges in the 21<sup>st</sup> century, particularly in developing countries and is associated with a high risk of morbidity and mortality. Children are the most vulnerable group to the effects of acute malnutrition during the period of their most rapid physical growth and development, because of the extra nutritional requirements for growth and development at this time. Acute malnutrition results from the complex interplay of a range of distal and proximal factors. This review article gives a comprehensive background on the causes of acute malnutrition among children under five years of age.</p> 2023-02-01T00:00:00+00:00 ##submission.copyrightStatement## Perceived Family Support and Medication Adherence among Diabetic Patients with Good and Poor Glycaemic Control Attending a Teaching Hospital in South-Western Nigeria 2023-01-25T11:42:23+00:00 A. Z. Adebobola T. E. Attoye A. I. Akinwumi O. A. Ewedairo O. A. Adebobola <p><strong>Aim: </strong>To compare perceived family support (PFS) and medication adherence among adult T2DM patients with good and poor glycaemic control.</p> <p><strong>Methods: </strong>This was a hospital-based cross-sectional comparative study among patients with T2DM. The participants were systematically recruited and divided into two groups after glycated haemoglobin testing. Additional data was collected using a structured interviewer – administered questionnaire adapted from Perceived Social Support – Family Scale and 8-item Modified Morisky Adherence Scale.</p> <p><strong>Results:</strong> The mean PFS scores among participants with good and poor glycaemic control were 16.37 and 13.97 points respectively. The difference between their mean scores was significant (<em>P</em> 0.000). The mean score of medication adherence among participants with good glycaemic control was 7.13 points while participants with poor glycaemic control had a mean score of 6.42 points. The difference between their mean scores was significant (<em>P</em> 0.012). A statistically significant association was found between medication adherence and glycaemic control (<em>P</em> 0.025).</p> <p><strong>Conclusions: </strong>This study found that T2DM participants with stronger PFS and better medication adherence had better glycaemic control than participants with weaker PFS and poor medication adherence. It is therefore important to emphasise family support and measures that improve medication adherence in the holistic management of T2DM.</p> 2023-01-25T00:00:00+00:00 ##submission.copyrightStatement## Molecular Characterization and Antibiogram of Staphylococcus and Pseudomonas Species Isolated from Patients Attending Rivers State Teaching Hospital, Nigeria 2023-02-04T10:40:29+00:00 U. Oparaodu L. B. Kpormon N. N. Odu <p>Disease of ear, nose and throat (ENT) affect the functioning of adults as well as children, often with significant challenge to of the daily life of affected patients. <em>Staphylococcu</em>s and <em>Pseudomonas </em>species are the most prevalent etiologic agent of ENT infections. Therefore the aim of this study was to determine the antibiogram of molecularly Characterized the <em>Staphylococcu</em>s and <em>Pseudomonas</em> species in the Ear and Throat among Patients Attending Rivers State Teaching Hospital. Total number of eighty samples of throat swab, and aural (ear) swab were collected aseptically using sterile Evepon swab sticks and the sample collected were properly labelled with patients' number, date and the side. The swabs were immediately transported with a transportation medium in sterile cotton plugged test tube to the microbiology laboratory for further analysis. Qquestionnaires were administered for degraphic data collections. Each throat and aural swab sample was inoculated onto Mannitol salt agar and Cetrimide agar plates for isolation of <em>Staphylococcus</em> and <em>Pseudomonas</em> species respectively. The plates were incubated at 37°C and examined for growth after 24-48 hours. Pure culture of the isolates were primarily identified biochemically and confirmed using molecular approaches. Antibiogram of the isolates was performed by the Kirby-Bauer disk diffusion method on Mueller-Hinton agar according to Clinical and Laboratory Standards Institute guideline. Results shows that out of the 50 ear swabs and 30 throat swab samples, 17 (34%) and 8 (26.7%) of the throat swabs ear swabs were positive of <em>Pseudomonas</em> spp. While for the <em>Staphylococcus</em> spp. 8 (16%) out of the 50 ear swabs and 4 (13.7%) out of 30 throat swabs were positive. The molecular results of the isolates shows that <em>Pseudomonas fluorescens</em> NR_115715.1, <em>Pseudomonas aeruginosa</em> NR_113599.1.</p> <p><em>Staphylococcus aureus</em> NR_113956.1. were the predominates species isolated from both ear and throat swabs. The results of antibiogram of the <em>Staphylococcus</em> and <em>Pseudomonas</em> species isolated revealed that commonly uses antibiotics especially Ceftazidime, Cefuroxime, Cloxacillin Gentamicin and Augmentin were 100% resistant to the isolates only Ofloxacin, Ceftriaxone and Nitrofurantoin were susceptible to the isolates with a percentage of 80.2%, 85.7% and 90%. The findings of this study points to the high level of frequent and indescrimate uses of antibiotics among patient suffering from symptoms of ENT resulting to difficulty in the treatment of infections using common antibiotics. It is strongly recommended that ccontinuous monitoring of patients is required for preparing antibiograms. These susceptibility results will help the physician for deciding the empirical regime for the patients.</p> 2023-02-04T00:00:00+00:00 ##submission.copyrightStatement## Possible Colchicine Poisoning: Case Study 2023-02-03T11:14:49+00:00 Koh Takeuchi Shinya Matsumoto Yusuke Yasumoto Ryotaro Kato <p>We have experienced a case of colchicine toxicity presenting with rapidly progressive gastrointestinal symptoms, hemodynamic instability, and multiple organ failure.</p> <p>An 86-year-old Japanese man presented to our hospital with subarachnoidal hemorrhage transferring from another hospital where he had been treated with colchicine 0.5 mg three times daily for an elevated uric acid level. During his admission, he had a nosocomial COVID-19 infection. Then, he developed loss of appetite, and significant diarrhea, which continued for two days. He then developed shock and hypoxia and was transferred to intensive care unit (ICU). The laboratory data revealed pancytopenia, acute kidney injury, lactic acidosis, marked coagulopathy, elevated troponin I, and C-reactive protein with poor cardiac function and hypotension refractory to vasopressors. Despite intensive care, he expired on 2nd day of ICU admission. Because his cardiac function was depressed from the beginning and was not respond to inotropic support, direct myocardial damage, rather than septic cardiomyopathy was suspected. We, therefore, emphasize that colchicine poisoning should be suspected in patients with access to the drug and the typical toxidrome.</p> 2023-02-03T00:00:00+00:00 ##submission.copyrightStatement##